Intellectual Property India Publishes Patent Application for A Novel Benzothiazole–thiazolidine-2,4-Dione–1,2,3-Triazole Hybrid Compound, Pharmaceutical Composition Thereof, And Method For The Preparation And Therapeutic Application Thereof

MUMBAI, India, Aug. 24 -- Intellectual Property India has published a patent application (202641098372 A) filed by Chaitanya Deemed To Be University on August 13, 2026, for A Novel Benzothiazole–thiazolidine-2,4-Dione–1,2,3-Triazole Hybrid Compound, Pharmaceutical Composition Thereof, And Method For The Preparation And Therapeutic Application Thereof.

Inventors include Dr. M. Ravinder; Advaitha Vanaparthy; and Dr. T. Narasimha Swamy.

The application for the patent was published on August 21, 2026, under issue no. 34/2026.

Abstract: The present invention relates to novel benzothiazole–thiazolidine-2,4-dione–1,2,3-triazole hybrid compounds, pharmaceutical compositions thereof, and a method for their preparation for therapeutic applications...